Jamjoom Pharmaceuticals Factory Company (SASE: 4015)
Health Care · Pharmaceuticals · SA
SR142.00
+1.43% today · -12.5% 1Y
Jamjoom Pharmaceuticals Factory Company (SASE: 4015) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.65B.
Over the last twelve months the share price has lost 12.5%, trading between 125.00 and 165.30.
Tweenvest scores Jamjoom Pharmaceuticals Factory Company across four factors: quality 74/100, value 83/100, dividend 60/100. Its strongest factor is value.
4015 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.65B
- Revenue (TTM)
- $418.84M
- P/E
- 20.68
- EPS
- 6.87
- Dividend yield
- 3.10%
- Beta (5Y)
- 0.34
- 52-week high
- SR165.30
- 52-week low
- SR125.00
- Avg volume (3M)
- —
- Shares outstanding
- 70.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.